CL
Insider
Cormorant Asset Management, LP
OtherCormorant Asset Management, LP (Other) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 2 sales), most often in DRUG. The largest single filing was $9.8M of DRUG (109,331 sh × $89.50, as filed), executed Apr 28.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.7M
shares × price, as filed
Last traded
Apr 28
Filed Apr 30
Volume by month
Buys $4.0M
Sells $10.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
2 filings
Sector per market data · by filing · past 12 months
Most traded names
DRUG
DRUG
DRUG · 1 buy · 1 sell
2 filings
EYPT
EYPT
EYPT · 0 buys · 1 sell
1 filing
Recent filings
DRUGSALE
BRIGHT MINDS BIOSCIENCES INC.
View filing →
$9.8M109,331 sh × $89.50
Exec Apr 28
Filed Apr 30 · 5:30 PM ET EYPTSALE EyePoint, Inc. View filing → $942K
60,000 sh × $15.70
Exec Dec 4 2025
Filed Dec 8 2025 · 5:30 PM ET DRUGPURCHASE BRIGHT MINDS BIOSCIENCES INC. View filing → $4.0M
184,331 sh × $21.70
Exec Nov 4 2024
Filed Nov 6 2024 · 5:30 PM ET